Objectively measured physical activity and plasma metabolomics in the Shanghai Physical Activity Study

International Journal of Epidemiology

Volumn 45, Issue 5, 2016, Pages 1433-1444

  Xiao, Qian ^a   Moore, Steven C ^a   Keadle, Sarah K ^a   Xiang, Yong Bing ^b   Zheng, Wei ^c   Peters, Tricia M ^d   Leitzmann, Michael F ^e   Ji, Bu Tian ^a   Sampson, Joshua N ^a   Shu, Xiao Ou ^c   Matthews, Charles E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Chronotype; Metabolomics; Sleep duration; Sleep timing

Indexed keywords

CARBOHYDRATE; GLUCOSE; ISOLEUCINE; LEUCINE; MANNOSE; VALINE; AMINO ACID; LIPID;

ACCELEROMETRY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHINA; ENERGY EXPENDITURE; FEMALE; HUMAN; MALE; METABOLOMICS; PHYSICAL ACTIVITY; PHYSICAL ACTIVITY ENERGY EXPENDITURE; PLASMA; PRIORITY JOURNAL; QUESTIONNAIRE; SEDENTARY LIFESTYLE; SEDENTARY TIME; BLOOD; ENERGY METABOLISM; EVALUATION STUDY; EXERCISE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ACCELEROMETRY; ADULT; AGED; AMINO ACIDS; BODY MASS INDEX; CHINA; ENERGY METABOLISM; EXERCISE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LINEAR MODELS; LIPIDS; MALE; METABOLOMICS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84994276742     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw033     Document Type: Article

References (50)

1. Li J, Siegrist J. Physical activity and risk of cardiovascular disease - a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012;9:391–407.
2. Prakash RS, Voss MW, Erickson KI, Kramer AF. Physical activity and cognitive vitality. Ann Rev Psychol 2015;66:769–97.
3. Grontved A, Pan A, Mekary RA et al. Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women. PLoS Med 2014;11:e1001587.
4. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002;136:493–503.
5. Gomez-Cabello A, Ara I, Gonzalez-Aguero A, Casajus JA, Vicente-Rodriguez G. Effects of training on bone mass in older adults: a systematic review. Sports Med 2012;42:301–25.
6. Johnson CM, Wei C, Ensor JE et al. Meta-analyses of colorec-tal cancer risk factors. Cancer Causes Control 2013;24: 1207–22.
7. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 2013;137:869–82.
8. Keum N, Ju W, Lee DH et al. Leisure-time physical activity and endometrial cancer risk: dose-response meta-analysis of epidemiological studies. Inte J Cancer 2014;135:682–94.
9. Kuhl J, Moritz T, Wagner H et al. Metabolomics as a tool to evaluate exercise-induced improvements in insulin sensitivity. Metabolomics 2008;4:273–82.
10. Huffman KM, Slentz CA, Bateman LA et al. Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity. Diabetes Care 2011;34:174–76.
11. Kujala UM, Makinen VP, Heinonen I et al. Long-term leisure-time physical activity and serum metabolome. Circulation 2013;127:340–48.
12. Floegel A, Wientzek A, Bachlechner U et al. Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study. Int J Obes (Lond) 2014;38:1388–96.
13. Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med 2015;162:123–32.
14. Powell KE, Paluch AE, Blair SN. Physical activity for health: What kind? How much? How intense? On top of what? Ann Rev Public Health 2011;32:349–65.
15. Duvivier BM, Schaper NC, Bremers MA et al. Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable. PloS One 2013;8:e55542.
16. Peters TM, Moore SC, Xiang YB et al. Accelerometer-measured physical activity in Chinese adults. Am J Prev Med 2010; 38:583–91.
17. Zheng W, Chow WH, Yang G et al. The Shanghai Women’s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123–31.
18. Shu XO, Li H, Yang G et al. Cohort Profile: The Shanghai Men’s Health Study. Int J Epidemiol 2015;44:910–18.
19. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008;40:181–88.
20. Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998;30:777–81.
21. Matthews CE, Chen KY, Freedson PS, et al. Amount of time spent in sedentary behaviours in the United States, 2003-2004. Am J Epidemiol 2008;167:875–81.
22. Matthews CE, Ainsworth BE, Hanby C et al. Development and testing of a short physical activity recall questionnaire. Med Sci Sports Exerc 2005;37:986–94.
23. Matthew CE. Calibration of accelerometer output for adults. Med Sci Sports Exerc 2005;37(Suppl 11):S512–22.
24. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009;81:6656–67.
25. Sampson JN, Boca SM, Shu XO et al. Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev 2013;22:631–40.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88.
27. Batch BC, Hyland K, Svetkey LP. Branch chain amino acids: biomarkers of health and disease. Curr Opin Clin Nutr Metab Care 2014;17:86–89.
28. Tom A, Nair KS. Assessment of branched-chain amino acid status and potential for biomarkers. J Nutr 2006;136(Suppl 1):324–30S.
29. Cheng S, Rhee EP, Larson MG et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012;125:2222–31.
30. Leskinen T, Rinnankoski-Tuikka R, Rintala M et al. Differences in muscle and adipose tissue gene expression and cardiometabolic risk factors in the members of physical activity discordant twin pairs. PloS One 2010;5:e12609.
31. Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 2014;10:723–36.
32. Harris RA, Joshi M, Jeoung NH, Obayashi M. Overview of the molecular and biochemical basis of branched-chain amino acid catabolism. J Nutr 2005;135(Suppl 6):1527–30S.
33. Kainulainen H, Hulmi JJ, Kujala UM. Potential role of branched-chain amino acid catabolism in regulating fat oxidation. Exerc Sport Sci Rev 2013;41:194–200.
34. Moore SC, Matthews CE, Sampson JN et al. Human metabolic correlates of body mass index. Metabolomics 2014;10:259–69.
35. Tai ES, Tan ML, Stevens RD et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010;53:757–67.
36. Davalli AM, Perego C, Folli FB. The potential role of glutamate in the current diabetes epidemic. Acta Diabetol 2012;49:167–83.
37. Ferrannini E, Natali A, Camastra S et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 2013;62:1730–37.
38. Gall WE, Beebe K, Lawton KA et al. Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PloS One 2010;5:e10883.
39. Sone H, Shimano H, Ebinuma H et al. Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects. Metabolism 2003;52:1019–27.
40. Pitkanen OM, Vanhanen H, Pitkanen E. Metabolic syndrome is associated with changes in D-mannose metabolism. Scand J Clin Lab Invest 1999;59:607–12.
41. Griffith OW, Bridges RJ, Meister A. Transport of gamma-glutamyl amino acids: role of glutathione and gamma-glutamyl transpeptidase. Proc Natl Acad Sci U S A 1979;76:6319–22.
42. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018–23.
43. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327–30.
44. Liu CF, Zhou WN, Fang NY. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Int J Clin Pract 2012;66:692–98.
45. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transfer-ase: a novel cardiovascular risk biomarker. Prev Cardiol 2010;13:36–41.
46. Zeisel SH. Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis. Clin Chem Lab Med 2013;51:467–75.
47. Kim MJ, Yang HJ, Kim JH et al. Obesity-related metabolomic analysis of human subjects in black soybean peptide intervention study by ultraperformance liquid chromatography and quadrupole-time-of-flight mass spectrometry. J Obes 2013;2013:874981.
48. Craig SA. Betaine in human nutrition. Am J Clin Nutr 2004;80:539–49.
49. Debolt S, Melino V, Ford CM. Ascorbate as a biosynthetic precursor in plants. Ann Bot (Lond) 2007;99:3–8.
50. Dunstan DW, Salmon J, Owen N et al. Physical activity and television viewing in relation to risk of undiagnosed abnormal glucose metabolism in adults. Diabetes Care 2004;27:2603–09.